Treatment with stromal vascular fraction of Peyronie's disease - a study protocol

Majken Højrup Wiborg1,2, Rasmus Krøijer2,3, Birgitte Schantz Laursen4,5

  • 1Department of Urology, Hospital South West Jutland, Region of Southern Denmark.

Danish Medical Journal
|October 28, 2023
PubMed
Abstract

Insights

This pilot study explores stromal vascular fraction injections for Peyronie´s disease. The treatment appears safe and effective for reducing penile curvature in men.

Area of Science:

  • Regenerative Medicine
  • Urology
  • Andrology

Background:

  • Peyronie´s disease involves fibrotic plaque formation in the tunica albuginea, affecting up to 9% of men.
  • This condition can lead to significant penile curvature, negatively impacting quality of life, self-esteem, sexual performance, and mental health.

Purpose of the Study:

  • To investigate the feasibility and safety of injecting stromal vascular fraction (SVF) into the fibrotic plaque of men with chronic-phase Peyronie´s disease.
  • To assess the potential of SVF injections in reducing penile curvature.

Main Methods:

  • A prospective pilot study involving 22 men diagnosed with chronic Peyronie´s disease.
  • Stromal vascular fraction was obtained from a 250 ml lipoaspirate under general anesthesia and injected into the plaque on the same day.

Main Results:

  • The study aimed to demonstrate the safety and efficacy of SVF injections.
  • Results are pending further analysis, but the primary goal is to show a reduction in penile curvature.

Conclusions:

  • Stromal vascular fraction injection is a potential novel therapeutic approach for Peyronie´s disease.
  • Further research is warranted to confirm the long-term safety and efficacy of this treatment in a larger patient cohort.